VZV immune globulin VZV immune globulin VZV (varicella zoster virus) globulin or VZV antibodies is an immune system medication that is used mostly for immunosuppressed patients who have been or may be exposed to the varicella zoster virus. It shortens the course of cutaneous disease and may protect against its dissemination. Varicella zoster virus is a human herpes virus that causes chickenpox, shingles, Ramsay Hunt syndrome type II, and postherpetic neuralgia. Unlike a Zoster vaccine which provides durable immunity, the protection is passive and short term; it may need to be readministered every 2-4 weeks as necessary. This medication is not recommended for
International Society for Disease Surveillance biosurveillance. Every year, the ISDS conference draws over 350 professionals from a broad range of disciplines to learn the latest achievements, analytic methods, best practices, conceptual frameworks, and technical innovations in the rapidly evolving field of disease surveillance. The ISDS conferences provide fertile ground for cultivating new ideas and partnerships by bringing together local, state, and federal public health practitioners, academic researchers, clinicians, policymakers, and decision makers from governmental and nongovernmental entities. The 12th annual conference was held in December 2013, in New Orleans, LA. The theme for the 2013 conference—Translating Research and Surveillance into Action—highlighted one of the salient